3D Bioprinting Market By Technology (Microextrusion, Inkjet, Laser, Magnetic), Material (Cells, Hydrogels, Extracellular Matrices, Biomaterials), Application (Clinical (Bone, Cartilage, Skin) & Research (Regenerative Medicine))and Regional Market Size, Status and Forecast to 2025

The global 3D Bioprinting Market was valued at USD 411.32 million in 2016 and is projected to reach USD 3394.93 million by 2025, growing at a CAGR of 26.43% from 2017 to 2025.

Download sample pages of this report:- http://bit.ly/2tIPSDW   

Three dimensional (3D) bioprinting is the utilization of 3D printing and 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics.

Companies Profiled in this report includes:- 1. Organovo Holdings, Inc.  2. Envisiontec GmbH  3. Nano 3D Biosciences, Inc.  4. Cyfuse Biomedical K.K.  5. Regenhu Ltd.  6. Aspect Biosystems Ltd.  7. Biobots 8. Cellink 9. Gesim 10. Poietis 11. Regenovo Biotechnology Co., Ltd.  12. 3Dynamic Systems Ltd.

Spritam (levetiracetam) manufactured by Aprecia Pharmaceutical, a specialty pharmaceutical company, became the first 3D bio-printed drug to gain FDA approval in March 2016. The application of 3D bioprinting in pharmaceutical manufacturing is expected to grow, thereby, contributing to the market growth during the forecast period.

Full Reports Information:- http://www.kminsights.com/reports/global-3d-bioprinting-market-by-technology–microextrusion–inkjet–laser–magnetic—material–cells–hydrogels–extracellular-matrices–biomaterials—application–clinical–bone–cartilage–skin—-research–regenerative-medicine–and-regional-market-size–status-and-forecast-to-2025-173519

Rising incidences of chronic illnesses leading to organ and tissue transplants coupled with the increasing life span of individuals and limited number of organ donors are expected to be the major drivers for the market growth. The advancement in technology and incorporation of IT within the healthcare industry, rising geriatric population base, and improving R&D efforts for the sector is also expected to propel the 3D bioprinting market over the forecast period.

Table of Content:-

1 INTRODUCTION OF GLOBAL 3D BIOPRINTINGMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL 3D BIOPRINTINGMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL 3D BIOPRINTING MARKET, BY MATERIAL
5.1 Hydrogels
5.2 Extracellular Matrices
5.3 Living Cells
5.4 Other Biomaterials

6 GLOBAL 3D BIOPRINTING MARKET, BY APPLICATION
6.1 Research Applications
6.1.1 Drug Research
6.1.2 Regenerative Medicine
6.1.3 3D Cell Culture
6.2 Clinical Applications
6.2.1 Skin
6.2.2 Bone & Cartilage
6.2.3 Blood Vessels

Download sample pages of this report:- http://bit.ly/2tIPSDW                        

About Us:
Key Market Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.

Contact:

Mr. Mannan
sales@kminsights.com
+1 (888) 278-7681